Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
2.290
+0.040 (1.78%)
At close: Oct 13, 2025, 4:00 PM EDT
2.320
+0.030 (1.31%)
After-hours: Oct 13, 2025, 7:54 PM EDT
Spero Therapeutics Market Cap
Spero Therapeutics has a market cap or net worth of $128.87 million as of October 13, 2025. Its market cap has increased by 86.27% in one year.
Market Cap
128.87M
Enterprise Value
101.29M
1-Year Change
86.27%
Ranking
Category
Stock Price
$2.29
Market Cap Chart
Since November 2, 2017, Spero Therapeutics's market cap has decreased from $159.82M to $128.87M, a decrease of -19.37%. That is a compound annual growth rate of -2.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 126.62M | 125.49% |
| Dec 31, 2024 | 56.15M | -27.92% |
| Dec 29, 2023 | 77.91M | -13.02% |
| Dec 30, 2022 | 89.57M | -82.69% |
| Dec 31, 2021 | 517.50M | -1.83% |
| Dec 31, 2020 | 527.17M | 186.63% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 2, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 748.25B |
| Johnson & Johnson | 459.32B |
| AbbVie | 407.19B |
| UnitedHealth Group | 321.06B |
| AstraZeneca | 264.75B |
| Novo Nordisk | 260.80B |
| Novartis AG | 253.85B |
| Abbott Laboratories | 230.73B |